Загрузка...
PARP inhibition sensitizes endometrial cancer cells to paclitaxel-induced apoptosis
PARP inhibitors are used in the treatment of gynecological malignancies and it has been demonstrated in preclinical studies that PARP inhibition sensitizes cancer cells to cytotoxic agents. In the present study, PARP expression was detected in different endometrial cancer cell lines by western blot...
Сохранить в:
Опубликовано в: : | Oncol Lett |
---|---|
Главные авторы: | , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
D.A. Spandidos
2017
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5403547/ https://ncbi.nlm.nih.gov/pubmed/28454476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5795 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|